Exact Mass: 394.064
Exact Mass Matches: 394.064
Found 41 metabolites which its exact mass value is equals to given mass value 394.064,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
JNJ-7706621
4-({5-Amino-1-[(2,6-Difluorophenyl)carbonyl]-1h-1,2,4-Triazol-3-Yl}amino)benzenesulfonamide
Demethyltorosaflavone C
cis-(+-)-2-(3,4-Dihydroxyphenyl)-5b,8a-dihydro-5,7-dihydroxy-6-methyl-4H,8H-cyclopenta[4,5]furo[3,2-g]-1-benzopyran-4,8-dione
methyl salicylate beta-D-glucopyranosyl-4-sulphate|sulfatricalysine A
methyl salicylate beta-D-glucopyranosyl-4-sulphate|sulfatricalysine A
Daphnoretine Acetate
Daphnoretine Acetate
relative retention time with respect to 9-anthracene Carboxylic Acid is 1.101 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.102
7-O-acetyldaphnoretin
6-Methoxy-2-oxo-3-(2-oxochromen-7-yloxy)chromen-7-yl acetate
Origin: Plant, Coumarins
phenyl 1,4-diamino-9,10-dihydro-9,10-dioxoanthracene-2-sulphonate
phenyl 1,4-diamino-9,10-dihydro-9,10-dioxoanthracene-2-sulphonate
2-(4-methoxyphenyl)-3-(2-methyl-5-nitrophenyl)sulfonyl-1,3-thiazolidine
2-(4-methoxyphenyl)-3-(2-methyl-5-nitrophenyl)sulfonyl-1,3-thiazolidine
2-(2-Methoxyphenyl)-3-[(2-methyl-5-nitrophenyl)sulfonyl]-1,3-thia zolidine
2-(2-Methoxyphenyl)-3-[(2-methyl-5-nitrophenyl)sulfonyl]-1,3-thia zolidine
2-chloro-N-[3-cyano-4-[(4-methoxyphenyl)thio]phenyl]benzamide
2-chloro-N-[3-cyano-4-[(4-methoxyphenyl)thio]phenyl]benzamide
3-chloro-N-[3-cyano-4-[(4-methoxyphenyl)thio]phenyl]benzamide
3-chloro-N-[3-cyano-4-[(4-methoxyphenyl)thio]phenyl]benzamide
2-{4-[(2-Aminophenyl)thio]-3-nitrobenzoyl}benzoic acid
2-{4-[(2-Aminophenyl)thio]-3-nitrobenzoyl}benzoic acid
4-(1,3-dioxo-2-isoindolyl)-N-(4-methyl-2-pyrimidinyl)benzenesulfonamide
4-(1,3-dioxo-2-isoindolyl)-N-(4-methyl-2-pyrimidinyl)benzenesulfonamide
2-[[5-Cyano-2-(3,4-dimethoxyphenyl)-4-oxo-2,3-dihydro-1,3-thiazin-6-yl]thio]acetic acid ethyl ester
2-[[5-Cyano-2-(3,4-dimethoxyphenyl)-4-oxo-2,3-dihydro-1,3-thiazin-6-yl]thio]acetic acid ethyl ester
N2,N9-dimethyl-11-oxo-5,6-dihydrodibenzo[3,1-b:3,1-f][7]annulene-2,9-disulfonamide
N2,N9-dimethyl-11-oxo-5,6-dihydrodibenzo[3,1-b:3,1-f][7]annulene-2,9-disulfonamide
N-[3-(3H-1,3-benzoxazol-2-ylidene)-4-oxo-1-cyclohexa-1,5-dienyl]-2-(4-chlorophenoxy)acetamide
N-[3-(3H-1,3-benzoxazol-2-ylidene)-4-oxo-1-cyclohexa-1,5-dienyl]-2-(4-chlorophenoxy)acetamide
(7Z)-2-Amino-4-(2-chlorophenyl)-7-[(2-chlorophenyl)methylidene]-5,6-dihydro-4H-cyclopenta[b]pyran-3-carbonitrile
(7Z)-2-Amino-4-(2-chlorophenyl)-7-[(2-chlorophenyl)methylidene]-5,6-dihydro-4H-cyclopenta[b]pyran-3-carbonitrile
ARN19874
ARN19874
ARN19874 is a selective, reversible uncompetitive N-acylphosphatidylethanolamine phospholipase D (NAPE-PLD) activity inhibitor with an IC50 of ~34 μM[1].
6-methoxy-2-oxo-3-[(2-oxochromen-7-yl)oxy]chromen-7-yl acetate
6-methoxy-2-oxo-3-[(2-oxochromen-7-yl)oxy]chromen-7-yl acetate
methyl (2r)-2,4,7-trihydroxy-3-oxo-2',4'-dioxaspiro[indene-1,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaene-2-carboxylate
methyl (2r)-2,4,7-trihydroxy-3-oxo-2',4'-dioxaspiro[indene-1,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaene-2-carboxylate
(1s,2r,4s,12s,13r)-7-hydroxy-13-methoxy-3,11,21,22-tetraoxaheptacyclo[10.9.1.1¹,⁶.1¹²,¹⁶.0²,⁴.0¹⁰,²⁴.0²⁰,²³]tetracosa-6(24),7,9,16,18,20(23)-hexaene-5,15-dione
(1s,2r,4s,12s,13r)-7-hydroxy-13-methoxy-3,11,21,22-tetraoxaheptacyclo[10.9.1.1¹,⁶.1¹²,¹⁶.0²,⁴.0¹⁰,²⁴.0²⁰,²³]tetracosa-6(24),7,9,16,18,20(23)-hexaene-5,15-dione
(1r)-2-ethyl-5,7,9-trihydroxy-4,6,11-trioxo-1h-tetracene-1-carboxylic acid
(1r)-2-ethyl-5,7,9-trihydroxy-4,6,11-trioxo-1h-tetracene-1-carboxylic acid
methyl 2,4,7-trihydroxy-3-oxo-2',4'-dioxaspiro[indene-1,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaene-2-carboxylate
methyl 2,4,7-trihydroxy-3-oxo-2',4'-dioxaspiro[indene-1,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaene-2-carboxylate
(11r,15s)-5-(3,4-dihydroxyphenyl)-9,13-dihydroxy-12-methyl-4,16-dioxatetracyclo[8.6.0.0³,⁸.0¹¹,¹⁵]hexadeca-1(10),2,5,8,12-pentaene-7,14-dione
(11r,15s)-5-(3,4-dihydroxyphenyl)-9,13-dihydroxy-12-methyl-4,16-dioxatetracyclo[8.6.0.0³,⁸.0¹¹,¹⁵]hexadeca-1(10),2,5,8,12-pentaene-7,14-dione
1,4-dimethyl 2-hydroxy-2-{5-hydroxy-7-methyl-4-oxo-2h,3h-thieno[2,3-b]chromen-2-yl}butanedioate
1,4-dimethyl 2-hydroxy-2-{5-hydroxy-7-methyl-4-oxo-2h,3h-thieno[2,3-b]chromen-2-yl}butanedioate
(13r)-7-hydroxy-13-methoxy-3,11,21,22-tetraoxaheptacyclo[10.9.1.1¹,⁶.1¹²,¹⁶.0²,⁴.0¹⁰,²⁴.0²⁰,²³]tetracosa-6(24),7,9,16,18,20(23)-hexaene-5,15-dione
(13r)-7-hydroxy-13-methoxy-3,11,21,22-tetraoxaheptacyclo[10.9.1.1¹,⁶.1¹²,¹⁶.0²,⁴.0¹⁰,²⁴.0²⁰,²³]tetracosa-6(24),7,9,16,18,20(23)-hexaene-5,15-dione
1,4-dimethyl 2-hydroxy-2-[(2s)-5-hydroxy-7-methyl-4-oxo-2h,3h-thieno[2,3-b]chromen-2-yl]butanedioate
1,4-dimethyl 2-hydroxy-2-[(2s)-5-hydroxy-7-methyl-4-oxo-2h,3h-thieno[2,3-b]chromen-2-yl]butanedioate
[4,5-dihydroxy-2-(hydroxymethyl)-6-[2-(methoxycarbonyl)phenoxy]oxan-3-yl]oxidanesulfonic acid
[4,5-dihydroxy-2-(hydroxymethyl)-6-[2-(methoxycarbonyl)phenoxy]oxan-3-yl]oxidanesulfonic acid
[(2r,3s,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[2-(methoxycarbonyl)phenoxy]oxan-3-yl]oxidanesulfonic acid
[(2r,3s,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[2-(methoxycarbonyl)phenoxy]oxan-3-yl]oxidanesulfonic acid
1,4-dimethyl (2s)-2-hydroxy-2-[(2s)-5-hydroxy-7-methyl-4-oxo-2h,3h-thieno[2,3-b]chromen-2-yl]butanedioate
1,4-dimethyl (2s)-2-hydroxy-2-[(2s)-5-hydroxy-7-methyl-4-oxo-2h,3h-thieno[2,3-b]chromen-2-yl]butanedioate
